GlassScriptPhysician profile
Selena J Stuart
NPI 1629236575
$6,498.57
in general payments reported to CMS, 2019-2025
40 companies · $233 in 2025
The $233 reported for 2025 was less than what a typical Hematology & Oncology provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,935 · 2020: $445 · 2021: $386 · 2022: $681 · 2023: $192 · 2024: $626 · 2025: $233.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,022 · Education: $29.44.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,021.89 |
| Education | $29.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,939.44 | 2019-2022 | |
| E.R. Squibb & Sons, L.L.C. | $1,076.18 | 2019-2025 | Opdivo |
| Pfizer INC. | $445.80 | 2019-2020 | |
| Amgen INC. | $340.56 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $325.96 | 2019-2021 | |
| Rigel Pharmaceuticals, INC. | $242.89 | 2021-2022 | |
| Astellas Pharma US INC | $180.40 | 2019-2025 | Vyloy |
| Eisai INC. | $148.35 | 2019 | |
| Medtronic, INC. | $130.58 | 2024 | Kyphon Express II Kyphopak Tray |
| Astrazeneca Pharmaceuticals LP | $123.63 | 2019-2020 | |
| Davol INC. | $118.67 | 2024 | Progel Applicator Spray Tips |
| Puma Biotechnology, INC. | $117.24 | 2019-2021 | |
| Verastem, INC. | $115.89 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $99.00 | 2022 | |
| Genentech USA, INC. | $96.14 | 2019-2024 | Polivy, Lunsumio |
Show all 39 companies
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Selena Stuart listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.